• money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home » Nifty Pharma

Nifty Pharma

  • Stocks To Watch

    Should you buy, sell or hold Dr Reddy’s post sharp fall?

    The pharma major reported a consolidated profit of Rs 570.8 crore for the quarter ended June 2021, 1.5% down from the year-ago period

  • Equities

    Market update: Banking & Pharma shine as RBI announces term liquidity facility of Rs 50,000 crore

    A liquidity window of Rs 50,000 crore with tenure of up to 3 years at repo rate being opened till March 31st, 2022. Under the scheme, banks can suppor

  • Equities

    Nifty Pharma at record highs, in for a long haul

    The Nifty Pharma index closed at record highs of 13,426 gaining 1.29% on Tuesday, while the benchmark Nifty index ended below 14,300-mark at 14,296 af

  • Equities

    Sensex reclaims 50,000; Nifty skyrockets 337 points

    At close, Sensex jumped 1,128 points, to 50,136 and the Nifty nears 14,850 marks at 14,845 ending 337 points higher.

  • Equities

    Biocon shares rally 1.38%

    Biocon Ltd is quoting at Rs 401.15, up 1.38% on the day as on 12:49 IST on the NSE. The stock is up 56.94% in last one year as compared to a 92.34% sp

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Contact Us
  • About Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2026 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close